• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.04
▲ +0.12 (13.04%)

This chart shows the closing price for DSS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DSS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DSS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DSS

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for DSS in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.04.

This chart shows the closing price for DSS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in DSS. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/17/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/15/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/24/2020AegisInitiated CoverageBuy$280.00
(Data available from 12/8/2019 forward)

News Sentiment Rating

-0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 23 positive mentions
  • 5 negative mentions
  • 11 very negative mentions
5/12/2024
  • 2 very positive mentions
  • 13 positive mentions
  • 12 negative mentions
  • 9 very negative mentions
6/11/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/11/2024
  • 1 very positive mentions
  • 16 positive mentions
  • 15 negative mentions
  • 14 very negative mentions
8/10/2024
  • 2 very positive mentions
  • 29 positive mentions
  • 9 negative mentions
  • 9 very negative mentions
9/9/2024
  • 3 very positive mentions
  • 20 positive mentions
  • 12 negative mentions
  • 8 very negative mentions
10/9/2024
  • 0 very positive mentions
  • 24 positive mentions
  • 17 negative mentions
  • 5 very negative mentions
11/8/2024
  • 1 very positive mentions
  • 25 positive mentions
  • 14 negative mentions
  • 7 very negative mentions
12/8/2024

Current Sentiment

  • 1 very positive mentions
  • 25 positive mentions
  • 14 negative mentions
  • 7 very negative mentions

Recent Stories by Sentiment

DSS logo
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
Read More

Today's Range

Now: $1.04
Low: $0.86
High: $1.08

50 Day Range

MA: N/A

52 Week Range

Now: $1.04
Low: $0.86
High: $3.08

Volume

93,235 shs

Average Volume

32,713 shs

Market Capitalization

$7.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Frequently Asked Questions

What sell-side analysts currently cover shares of DSS?

The following Wall Street analysts have issued research reports on DSS in the last year:
View the latest analyst ratings for DSS.

What is the current price target for DSS?

0 Wall Street analysts have set twelve-month price targets for DSS in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for DSS in the next year.
View the latest price targets for DSS.

What is the current consensus analyst rating for DSS?

DSS currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for DSS.

What other companies compete with DSS?

How do I contact DSS's investor relations team?

DSS's physical mailing address is 200 Canal View Blvd Ste 300, ROCHESTER, NY 14623-2851, United States. The business services provider's listed phone number is (585) 325-3610 and its investor relations email address is [email protected]. The official website for DSS is www.dsssecure.com. Learn More about contacing DSS investor relations.